Health Care & Life Sciences » Pharmaceuticals | Ind-Swift Ltd.

Ind-Swift Ltd. | Income Statement

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Sales/Revenue
5,654
4,172
3,043
2,631
2,706
Cost of Goods Sold (COGS) incl. D&A
5,696
4,838
3,280
2,806
2,371
Gross Income
41
666
237
175
335
SG&A Expense
582
424
1,584
3,382
993
EBIT
628
1,093
-
3,560
658
Unusual Expense
-
-
102
82
93
Non Operating Income/Expense
56
16
22
11
102
Interest Expense
768
399
190
163
71
Pretax Income
1,243
1,474
1,998
3,629
534
Income Tax
88
22
2
9
8
Equity in Affiliates
-
-
137
84
37
Consolidated Net Income
1,156
1,451
2,136
3,722
504
Net Income
1,156
1,451
2,136
3,722
504
Net Income After Extraordinaries
1,156
1,451
2,136
3,722
504
Net Income Available to Common
1,156
1,451
2,136
3,722
504
EPS (Basic)
24.49
28.83
42.42
68.73
9.36
Basic Shares Outstanding
47
50
50
54
-
EPS (Diluted)
23.94
28.83
42.42
68.73
-
Diluted Shares Outstanding
48
50
50
54
-
EBITDA
242
581
1,570
3,104
311
Other Operating Expense
5
2
112
3
-
Non-Operating Interest Income
96
2
2
1
-

About Ind-Swift

View Profile
Address
781, Industrial Area
Chandigarh Chandigarh 160002
India
Employees -
Website http://www.indswiftltd.com
Updated 09/14/2018
Ind-Swift Ltd. engages in the research, development, and commercialization of pharmaceutical products. It operates through the Domestic and Export segments. It offers therapeutic drugs such as antibiotics, anti-infectives, nutraceuticals, analgesics, anti-ulcer, hypolipidaemic medicines, expectorants, and anti-depressants.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.